Fudan University: Adenocarcinoma of Lung trials

The registry lists 12 Adenocarcinoma of Lung studies with Fudan University as lead sponsor. 8 are open to participants now and 0 have results posted.

Phase 2 2Phase 3 5No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Lymph Node Pathologic Grading StrategyRecruitingNCT06745830
• Segmentectomy for Solid-dominant Lung CancerRecruitingNCT06634966Phase 3
• Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018)RecruitingNCT06031246Phase 3
• Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019)RecruitingNCT06031181Phase 3
• Intraoperative Frozen Section Pathology to Guide Surgical Treatment for Lung Adenocarcinoma (ECTOP-1016)RecruitingNCT05794724
• Intraoperative Frozen Section Pathology to Guide Surgical Treatment for Lung Adenocarcinoma (ECTOP-1015)RecruitingNCT05794711
• Segmentectomy for Ground Glass-dominant Invasive Lung Cancer (ECTOP-1012)RecruitingNCT05717803Phase 3
• Adjuvant Chemotherapy for High Risk Stage I Lung AdenocarcinomaRecruitingNCT03380468Phase 2/3
• Intraoperative Frozen Section Pathology to Diagnose the IASLC Grades for Lung Adenocarcinoma (ECTOP-1014)CompletedNCT05794698
• Evaluation of Correlations Between Radiologic Features and Pathologic Subtypes of GGO LUAD Via WMS (ECTOP-1011)CompletedNCT05252676
• HRCT in Prediction of Tumor Invasion in GGO Lung Adenocarcinoma (ECTOP-1008)CompletedNCT04165759
• Pemetrexed and Platinum Use in the Neoadjuvant Setting for Resectable Stage II and IIIA Lung Adenocarcinoma (ECTOP-1002)CompletedNCT02980991Phase 2